{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:42:37Z","timestamp":1791265357995,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.39","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T11:21:11Z","timestamp":1448968871000},"page":"e265","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Evaluation of 2\u2019-Deoxy-2\u2019-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"4","author":[{"given":"Silvana M G","family":"Jirka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa L","family":"Tanganyika-de Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke W","family":"Boertje-van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Vermue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.39_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/mtna.2015.39_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/mtna.2015.39_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1038\/mtna.2015.39_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1038\/mtna.2015.39_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/hmg\/ddg100","article-title":"Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients","volume":"12","author":"Aartsma-Rus","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2015.39_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/rna.7.4.12264","article-title":"Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy","volume":"7","author":"Aartsma-Rus","year":"2010","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.39_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/nat.2013.0454","article-title":"A chemical view of oligonucleotides for exon skipping and related drug applications","volume":"24","author":"J\u00e4rver","year":"2014","journal-title":"Nucleic Acid Ther"},{"key":"10.1038\/mtna.2015.39_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/mtna.2015.39_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1038\/mtna.2015.39_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.39_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/JND-140013","article-title":"Dystrophin analysis in clinical trials","volume":"1","author":"Aartsma-Rus","year":"2014","journal-title":"JND"},{"key":"10.1038\/mtna.2015.39_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2013.09.004","article-title":"Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial","volume":"24","author":"Flanigan","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/mtna.2015.39_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nchembio.939","article-title":"Synthetic oligonucleotides recruit ILF2\/3 to RNA transcripts to modulate splicing","volume":"8","author":"Rigo","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1038\/mtna.2015.39_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymthe.2006.02.022","article-title":"Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons","volume":"14","author":"Aartsma-Rus","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.39_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jgm.295","article-title":"Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy","volume":"4","author":"Mann","year":"2002","journal-title":"J Gene Med"},{"key":"10.1038\/mtna.2015.39_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"10.1038\/mtna.2015.39_bib17","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1074\/jbc.M709410200","article-title":"Generation and characterization of transgenic mice with the full-length human DMD gene","volume":"283","author":"\u2018t Hoen","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2015.39_bib18","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/mt.2010.72","article-title":"Preclinical PK and PD studies on 2\u2019-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model","volume":"18","author":"Heemskerk","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.39_bib19","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/nar\/gkv298","article-title":"2\u2019-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF","volume":"43","author":"Shen","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.39_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/jm00059a007","article-title":"Uniformly modified 2\u2019-deoxy-2\u2019-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets","volume":"36","author":"Kawasaki","year":"1993","journal-title":"J Med Chem"},{"key":"10.1038\/mtna.2015.39_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/nar\/gkn904","article-title":"Potent inhibition of microRNA in vivo without degradation","volume":"37","author":"Davis","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.39_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1474-9726.2007.00306.x","article-title":"Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies","volume":"6","author":"Zhu","year":"2007","journal-title":"Aging Cell"},{"key":"10.1038\/mtna.2015.39_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF02634119","article-title":"Culturing satellite cells from living single muscle fiber explants","volume":"31","author":"Rosenblatt","year":"1995","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1038\/mtna.2015.39_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/abio.2002.5576","article-title":"Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma","volume":"304","author":"Yu","year":"2002","journal-title":"Anal Biochem"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T23:59:31Z","timestamp":1599868771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"alternative-id":["S2162253116300506"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.39","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e265"}}